Stephens Investment Management Group LLC lessened its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 5.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 618,696 shares of the biotechnology company’s stock after selling 33,304 shares during the quarter. Stephens […]

Stephens Investment Management Group LLC lifted its position in Neogen Co. (NASDAQ:NEOG – Free Report) by 2.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,606,121 shares of the company’s stock after purchasing an additional 52,522 shares during the quarter. Stephens Investment Management Group […]

Stephens Investment Management Group LLC grew its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 12.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,274,482 shares of the medical device company’s stock after buying an additional […]